Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 41
- Uncategorized
Aurora stärkt deutsche Position mit EU-GMP-Anlage
Die hochmoderne Anlage bereitet sich nun auf die erste Lieferung von medizinischem Cannabis für deutsche Patienten vor.
- Uncategorized
FDA issues warning over accidental THC ingestion by children
A number of edible THC products in the US are being mistaken for common foods by children.
- Medical
Guernsey to review legal status of cannabis
Guernsey will also explore medical cannabis as part of its post-Brexit economic recovery plan.
- Medical
Little Green Pharma to increase medical cannabis offering in UK
The company has signed a distribution agreement with Sana Life Sciences.
- Medical
New agreement to fund Phase II trials for cannabis glaucoma treatment
Emerald Health Therapeutics has signed an agreement with Skye Bioscience.
- Cultivation
Discover Europe’s first registered cannabis seedbank
The bank is home to the seeds of 286 strains, including 19 Cannabis Cup winners.
- Adult-Use
What can Uruguay teach the UK about cannabis policy?
Recreational cannabis has been legal in the country since 2013 – one think tank says Uruguay could help inform how to improve criminal and health outcomes in the UK.
- Companies
Cellular Goods makes changes to board, welcoming author as NED
The company is welcoming new non-executive directors (NED) to the board.
- CBD Market
Cannaray to drive brand awareness following successful fundraise
Blue Array will be assisting the company in its digital campaigns.
- Policy & Regulation
London Drugs Commission launched by Mayor to assess cannabis laws
The Mayor of London is visiting LA to see what lessons could be learned in the UK in responding to the challenges of drugs.
- Companies
Expanding the full digitisation of COAs in the cannabis supply chain
Lucid Green has announced three new partnerships to support the digitisation of certificates of analysis (COA).
- CBD Market
New chief technology officer appointed at High Tide
Greg Fleury has joined the CBD company.
